Developing Next Generation Anti-Fibrotic Therapeutics Utilizing Wnt Co-Receptor LRP6
This presentation will improve your understanding of cross-talk of different signalling pathways. Review these slides to discover how inhibition of critical central mediators could provide a more efficient therapeutic target for next generation CKD compounds.
An interview with Workshop Leader, Mahmoud Logham-Adham
Read the full interview where Mahmoud shares his perspectives around the current challenges limiting CKD drug development and where best to leverage insights to overcome these hurdles.